Financials

  • Market Capitalization 482.11 M
  • Employee 129
  • Founded 2018
  • CEO N/A
  • Website www.kyvernatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RCYMHR1
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.58
Price to sales ratio
-6 934.07

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2941
NVCT
Nuvectis Pharma, Inc. - Common Stock
18.26 USD-0.98%-4.90%+66.91%+118.16%484.36 M USD
2952
PROK
ProKidney Corp. - Class A Ordinary Shares
1.56 USD-3.11%-20.00%-6.02%-25.00%471.21 M USD
2961
SGMT
Sagimet Biosciences Inc. - Series A Common Stock
7.76 USD+8.53%+0.91%+18.29%-17.45%479.19 M USD
2969
RZLT
Rezolute, Inc. - Common Stock
4.84 USD+2.11%-2.62%+13.62%-9.02%466.05 M USD

Frequently asked questions about Kyverna Therapeutics, Inc. - Common Stock

What is the Kyverna Therapeutics, Inc. - Common Stock stock price today?

The current price of Kyverna Therapeutics, Inc. - Common Stock (KYTX) is 7.93. Over the past 24 hours, the stock has changed by +2.06%. Follow the KYTX chart for real-time price dynamics.

What is the stock ticker of Kyverna Therapeutics, Inc. - Common Stock?

Kyverna Therapeutics, Inc. - Common Stock trades under the ticker KYTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Kyverna Therapeutics, Inc. - Common Stock stock going up?

KYTX has changed by -18.08% over the last week, -3.53% over the last month, and +79.41% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Kyverna Therapeutics, Inc. - Common Stock net income for the last quarter?

Kyverna Therapeutics, Inc. - Common Stock reported net income of -39.73 M for the last quarter. The previous quarter showed -37.8 M, which means net income changed by -5.09%.

How many employees does Kyverna Therapeutics, Inc. - Common Stock have?

As of the latest available data, Kyverna Therapeutics, Inc. - Common Stock has 129 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Kyverna Therapeutics, Inc. - Common Stock stock?

You can buy Kyverna Therapeutics, Inc. - Common Stock (KYTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Kyverna Therapeutics, Inc. - Common Stock stock?

Investing in Kyverna Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KYTX chart and related analysis on metatrader.com as part of your research.